Navigation Links
Ames Laboratory researchers solve fuel-cell membrane structure conundrum
Date:12/11/2007

AMES, Iowa Fuel-cell cars are reaching commercial viability in todays increasingly eco-conscious society, but despite their promise, even scientists have struggled to explain just how the fuel-cells central component the proton exchange membrane really works.

However, a team of researchers at the U.S. Department of Energys Ames Laboratory has offered a new model that provides the best explanation to date for the membranes structure and how it functions. And armed with that information, scientists should be able to build similar fuel-cell membrane materials that are less expensive or have different properties, such as higher operating temperatures.

A fuel cell works by pumping hydrogen gas through the proton exchange membrane. In the process, the hydrogen gives up electrons in the form of electricity, then combines with oxygen gas to form water as the by-product. It can also work in reverse when current is applied, water is split into its component gases, hydrogen and oxygen.

The model proposed by Ames Laboratory scientists Klaus Schmidt-Rohr and Qiang Chen, and detailed in the Dec. 9 issue of the journal Nature Materials, looked specifically at Nafion, a widely used perfluorinated polymer film that stands out for its high selective permeability to water and protons. Schmidt-Rohr, who is also a professor of chemistry at Iowa State University, suggests that Nafion has a closely packed network of nanoscale cylindrical water channels running in parallel through the material.

From nuclear magnetic resonance (NMR), we know that Nafion molecules have a rigid backbone structure with hair-like defects along the chain, Schmidt-Rohr said, but we didnt know just how these molecule were arranged. Some have proposed spheroidal water clusters, others a web-like network of water channels.

Our theory is that these hydrophobic (water-hating) backbone structures cluster together, he continued, to form long rigid cylinders abo
'/>"/>

Contact: Kerry Gibson
kgibson@ameslab.gov
515-294-1405
DOE/Ames Laboratory
Source:Eurekalert

Page: 1 2

Related biology technology :

1. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
2. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
3. ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services
4. Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies
5. AviaraDx Announces CAP Accreditation of Its Laboratory Operations
6. Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use for HemosIL(R) D-Dimer HS Assay
7. New White Paper Details Six Steps to Investigate and Prevent Laboratory Accidents
8. Codexis Opens Singapore Laboratory
9. Stem Cell Leader Beike Biotech and Chinas Tsinghua University Receive US$4 Million for Stem Cell Reprogramming Laboratory
10. Researchers improve ability to write and store information on electronic devices
11. Long-awaited international ethical guidelines for biobank researchers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., Mass., Nov. 19 Arlington Medical...the leading driver of antibiotic selection in noso...ity against gram-positive and gram-negative pathog...e nosocomial pneumonia, surveyed European physicia... provide appropriate coverage against common patho...
(Date:11/19/2009)...nored by latest award for revolutionary hearing ai...ovember 16, 2009 -- Popular Science Magazine has n... from InSound Medical a winner of its coveted Best...    Chosen from thousands of e...earing canal for up to four months while providing...
(Date:11/18/2009)...tted postage stamp that can sniff out poisonous ga... As reported in the Sept. 13 issue of the journal...at the University of Illinois have developed an ar...ndustrial chemicals (TICs) that is simple, fast an...is sensor array could be useful in detecting high ...
(Date:11/18/2009)... U.K. and CLEVELAND, Nov. 18 TREK ...s and premier provider of diagnostic systems and s...expanded its East Grinstead, U.K., manufacturing a...asing global demand for its Sensititre® produ...ing. The expanded facility has been fully validate...
Breaking Biology Technology:Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 4
... March 20 ADVENTRX Pharmaceuticals, Inc. (NYSE Am...3, it will reduce its full-time workforce to five ...f its development activities and fundamental busin...mmate a strategic transaction or otherwise obtain ...will consist of its Chief Business Officer and Sen...
...arch 20 /PRNewswire-FirstCall/ - Oncolytics Biotec...interim clinical results from its Phase I/II U.K. ...oplatin for patients with advanced cancers were pr...icating Oncolytic Virus Therapeutics. The meeting ... 22nd, 2009. The principal investigator for the tr...
...rch 20 Solos Endoscopy, Inc. (Pink Sheets: SNDY) ... an agreement with Lifeline Biotechnologies, Inc. ...scope product line to Lifeline Biotechnologies for...her consideration. Solos Endoscopy originally pur...in 2007. , , Lifeline Biotechnologies has agreed ...
Other Biology Technology:ADVENTRX Announces Further Cost-Cutting Measures 2ADVENTRX Announces Further Cost-Cutting Measures 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Head and Neck Results in Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Trial 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Head and Neck Results in Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Trial 3Solos Endoscopy, Inc. Sells Ovascope and Mastascope Product Line to Lifeline Biotechnologies, Inc. 2
(Date:11/20/2009)...rth Grafton, Mass., November 19, 2009 The estimat...dustry may be at risk of developing respiratory sy...ording to a questionnaire study undertaken earlier...Cummings School of Veterinary Medicine. , The st...n workersfound that 50 percent of individuals work...
(Date:11/20/2009)...his release is available in German . , In t...l Investigation , Dr. Stefanie Eyerich and Dr. Kil...perial College London and Istituto Dermopatico del... discovery. It represents a milestone on the way t...y skin diseases such as psoriasis and allergic rea...
(Date:11/20/2009)...AMPAIGN, Ill. In a new study, researchers report ...kers can have a helpful, or harmful, effect on the... The study, which appears in the journal Circulat...t both the alpha- and beta-receptors on the heart ... while those that target only the beta-receptors c...
Breaking Biology News(10 mins):Barn personnel experience higher-than-average rates of respiratory symptoms 2Discovery of new type of immune cells regulating inflammation in chronic diseases 2Carvedilol shown to have unique characteristics among beta blockers 2Health Plans Return to Airwaves in Support of Bipartisan Reform 52104 1Health Plans Return to Airwaves in Support of Bipartisan Reform 52104 2Echo Therapeutics to Present at Jessup 26 Lamont 2009 Growth Stock Conference 52099 1Echo Therapeutics to Present at Jessup 26 Lamont 2009 Growth Stock Conference 52099 2New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine 28TDF FTC 29 Versus Boosted Protease Inhibitor Regimen of Atazanavir Rito 4747 1New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine 28TDF FTC 29 Versus Boosted Protease Inhibitor Regimen of Atazanavir Rito 4747 2New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine 28TDF FTC 29 Versus Boosted Protease Inhibitor Regimen of Atazanavir Rito 4747 3New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine 28TDF FTC 29 Versus Boosted Protease Inhibitor Regimen of Atazanavir Rito 4747 4New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine 28TDF FTC 29 Versus Boosted Protease Inhibitor Regimen of Atazanavir Rito 4747 5New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine 28TDF FTC 29 Versus Boosted Protease Inhibitor Regimen of Atazanavir Rito 4747 6
...t allergies successfully prevented allergic reacti...in a test tube, University of California, Los Ange...f Nature Medicine, available online now. In the fu...ts could lead to a new therapy not only for human ...llergies such as those to peanuts. , The National ...
...rch 30th edition of the prestigious scientific jou...tion of the UK,s national academy of science) show...mon farms to wild salmon populations is much large...his quantitative analysis of parasite transfer is ... is the first to isolate and measure the impact of...
...(mtDNA) play,an important role in the development ...tists at Emory University School of Medicine and t...are published online,this week in the Proceedings ...ondrial DNA, which is separate from nuclear DNA, i... the cytoplasm outside of,each cell,s nucleus. The...
Other Biology News:Novel Therapy Tested in Mice Could Chase Away Cat Allergies 2Novel Therapy Tested in Mice Could Chase Away Cat Allergies 3Researchers reveal the infectious impact of salmon farms on wild salmon 2Researchers reveal the infectious impact of salmon farms on wild salmon 3Researchers reveal the infectious impact of salmon farms on wild salmon 4Mitochondrial DNA mutations play significant role in prostate cancer 2
Mastercycler gradient from Eppendorf North America
Rnase-free Ribonuclease Inhibitor from Chimerx
...ion interface. All the functionality of the micro1...d memory and more available channels of waveform i...tion for programmable front-end gain. Can be expan... from 4 to 8 waveform outputs at 16 bit resolution...
...igned to provide a thin film-like barrier when a c...is barrier creates the proper surface tension to h... the slide. PAP Pen contains a special formulatio...an be removed, if desired, by xylene after the sta...
Biology Products: